Guide to Targeted Therapies: EGFR mutations in NSCLC
2014, XI, 67 p. 16 illus. in color.
Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.
You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.
After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.
A concise, practical handbook on EGFR mutations in NSCLC that provides oncologists and other healthcare providers with an up-to-date review of the background and advances in the field
Reviews the current treatment recommendations for EGFR mutations in NSCLC and emerging treatment options based on recent clinical trials
Easily accessible text, tables, and images reviews the critical clinical trials, giving readers a fast synopsis of key studies and available treatment options
Guide to Targeted Therapies: EGFR Mutations in NSCLC is a speedy and up-to-date review, which discusses EGFR mutations, testing methods and technology, current and emerging therapies, and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of EGFR gene mutations as well as a summary of current therapies will benefit from this succinct guide.